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.Introduction: Thoracic endovascular aortic repair (TEVAR) has become the main treatment of traumatic aortic
isthmic rupture. The long-term complications of TEVAR may be more important in a young patient population.
Report: A 33-year-old triathlete who had undergone successful TEVAR for aortic isthmus rupture, was diagnosed
with resistant hypertension 6 years later. CT angiography showed stent dislocation mimicking a coarctation. He
underwent successful surgical repair.
Discussion: Device collapse is a phenomenon observed after TEVAR for blunt thoracic aorta injury. Current testing
of endografts are insufﬁcient for the long lifespan of survivors of traumatic isthmic rupture. This case illustrates
this complication.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd.
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Open access under CC BY-NC-ND licenseINTRODUCTION
Thoracic endovascular aortic repair (TEVAR) has become the
main modality for treatment of traumatic aortic isthmic
rupture,1 particularly useful for patients with multiple, se-
vere injuries in whom anticoagulation and extracorporeal
support are contraindicated. Patients surviving this lethal
trauma are young, and the long-term complications of
TEVAR2,3 may be more important in this patient population
who will likely survive for a very long time with an endograft
and be at risk over a longer period of time for complications
of these stents, provided they survive the initial repair and
associated end-organ trauma. We report the management
of a late aortic stent dislocation presenting as resistant
hypertension in a triathlete.
REPORT
A 27-year-old male triathlete was an urgent admission to
another institution after a motor vehicle accident; he was
intubated and in shock. The CT scan showed a grade III
rupture of the aortic isthmus and was treated urgently with
a Gore TAG endograft (W.L. Gore and Associates, Flagstaff,
AZ, USA), covering the ostium of the left subclavian artery.
He had an uncomplicated postoperative course and was
discharged on the ﬁfth postoperative day. At 6 months’
follow-up, he underwent a routine computed tomography
(CT) scan, which showed a patent endograft with no sig-
niﬁcant endoleaks and no aneurysmal dilatation of the
thoracic aorta or aortic arch. The patient was allowed to
resume his usual triathlon training and had regular yearlyof original article: http://dx.doi.org/10.1016/j.ejvs.2013.05.002
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Open access under CC BY-NC-ND license.medical examinations. Five years later, the patient’s primary
care physician diagnosed new-onset hypertension at rest.
Despite an aggressive antihypertensive regimen, it was not
possible to control his hypertension. The medical workup
for this uncontrolled hypertension was negative. Six years
after his initial operation, a follow-up CT-scan of the
thoracic aorta demonstrated a dislocation of the proximal
part of the endovascular stent, closing the aortic lumen and
creating a quasi-closed diaphragm, mimicking an aortic
coarctation (Fig. 1). He was referred for surgical repair of
this stent dislocation 6 years after his initial TEVAR.
The distal aortic arch was approached through a median
sternotomy and right axillary artery cannulation. Under mild
hypothermia (28 C), the aortic arch was opened trans-
versally, proximal to the origin of the left subclavian artery.
The stent on the minor aortic arch curvature was dislocated,
closing the aortic lumen (Fig. 2). This dislocated stent
segment was cut to its lower hemicircumference and up to
the beginning of the descending aorta. The cut remnant was
ﬁxed against the aortic wall with a sandwich of Teﬂon
felt inside and outside the aorta, and the aortotomy was
closed. The postoperative course was uneventful. An early
CT scan showed a widely patent aortic arch, isthmus, and
descending aorta, and the patient was discharged on the
6th postoperative day.
At 6 months’ follow-up, the patient’s blood pressure was
within normal range without antihypertensive medications,
and he resumed training normally. The CT scan showed
stability and a favorable result.
DISCUSSION
In a recent meta-analysis, Jonker et al.4 reported signiﬁ-
cantly lower mortality and fewer pulmonary complications
in the TEVAR group than the surgery group, despite the fact
that patients in the TEVAR group had more major injuries.
Despite numerous encouraging reports from a large number
of publications in favor of TEVAR in the acute phase of
Figure 1. Computed tomographic angiography showing proximal
dislocation and near closure of the stent graft. (A) Axial view. (B)
Maximum intensity projection sagittal view.
Figure 2. Surgical view at repair, showing the dislocated stent
(white arrow) closing the aortic arch lumen. Ao ¼ aortic arch
opened longitudinally.
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to support an improvement in overall survival compared
with traditional surgical treatment. Device collapse is aphenomenon observed in 1e19% of TEVAR repairs for blunt
thoracic aorta injury, and is primarily attributable to
excessive device oversizing combined with a tight aortic
curvature radius.5 While typically noted within 30 days of
treatment, late device collapses have been reported up to 6
years after TEVAR and have been most commonly been
reported with the Gore TAG device.
Device durability after TEVAR is another issue in this
patient population. Clinical trials of endovascular stent
grafts regulated by the FDA typically mandate patient
follow-up for 5 years after treatment. Pulsatile fatigue
testing of thoracic endografts is generally simulated over
400 million cycles, equivalent to 10 years in vivo.
This testing is adequate for the study of thoracic aortic
aneurysm, since the typical patient lifespan after TEVAR is
7 years. However, survivors of TEVAR for blunt thoracic
aortic injury have an expected lifespan of several decades,
and long-term device durability becomes a major concern
and current stent graft evaluation methods are likely
inadequate.
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